Eccogene

Series-B
eccogene.com Biotech & Healthcare
Total Funding $25.2M
Latest Round $25.2M Series-B
Last Announced Jun 11, 2023
Investors Undisclosed
Decision Makers 4 Available

About Eccogene

Clinical stage biopharmaceutical company developing best-in-class small molecule therapeutics for chronic cardiometabolic and inflammatory conditions.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B
Global Headquarters Undisclosed
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website eccogene.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Raised $25,200,000 · Series-B

    startupintros.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Eccogene.

Funding History

1 Round
Series-B equity · Jun 11, 2023

Founders & Leadership

2

Jianfeng Xu

Co-founder & CSO

Work email & phone locked Unlock →

Jingye Zhou

Co-founder & CEO

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts